Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

3 Top ETFs I Plan to Buy in April


I like to make individual investments. I love being a part owner of something tangible that can grow my wealth over the long term.

However, despite my preference for being an active investor, I've passively invested in several high-quality exchange-traded funds (ETFs). I like to use ETFs to invest in a broader theme or another area I'm not comfortable investing in individually. I plan to add to my ETF holdings this month by buying a few more shares of SPDR Biotech ETF (NYSEMKT: XBI), SPDR Portfolio High Yield Bond ETF (NYSEMKT: SPHY), and JPMorgan Equity Premium Income ETF (NYSEMKT: JEPI). Here's why I plan to buy more of these high-quality ETFs this month.

Biotechnology is an amazing sector. It has made some remarkable breakthrough discoveries, including monoclonal antibodies, CRISPR, and mRNA-based vaccines. While I'm very interested in learning about science, most of what biotechnology companies do goes over my head. Because of that, I find investing directly in biotech stocks hard. They can be very risky since drug discovery and development can often have a binary outcome.

Continue reading


Source Fool.com

JPMorgan Chase & Co. Stock

€177.88
-0.980%
The price for the JPMorgan Chase & Co. stock decreased slightly today. Compared to yesterday there is a change of -€1.760 (-0.980%).
With 29 Buy predictions and not a single Sell prediction JPMorgan Chase & Co. is an absolute favorite of our community.
As a result the target price of 202 € shows a slightly positive potential of 13.56% compared to the current price of 177.88 € for JPMorgan Chase & Co..
Like: 0
XBI
Share

Comments